文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛心脑血管急症

吸入性挥发性麻醉药用于成人ICU与PICU的哮喘持续状态、癫痫持续状态及困难镇静:一项系统评价

Inhaled Volatiles for Status Asthmaticus, Epilepsy, and Difficult Sedation in Adult ICU and PICU: A Systematic Review.
PubMed 文献 · Crit Care Explor · 2024-02-20
一句话结论吸入性挥发性麻醉药可能在1–2小时内改善哮喘持续状态、癫痫持续状态及困难镇静,但证据质量低,最常见不良事件为低血压和心律失常。

该系统评价检索MEDLINE、Cochrane对照试验中心注册库和Embase,纳入1970至2021年报告在机械通气哮喘持续状态(SA)、癫痫持续状态(SE)和困难镇静(DS)患者中使用吸入性麻醉药的研究。共筛查4281项研究,纳入SA成人38项/121例、儿童28项/142例,SE成人18项/37例、儿童5项/10例,DS成人21项/355例、儿童10项/90例。证据质量低,以病例报告和病例系列为主;启动挥发性麻醉药后1–2小时内可见临床和生理改善,但疗效因诊断和患者群体而异;最常见不良事件为心血管事件(低血压和心律失常)。作者结论认为挥发性麻醉药可能提供有效治疗,但需要更高质量的前瞻性研究,并需要开展吸入性麻醉药教育及使用方案化。

要点

  • 纳入研究以病例报告和病例系列为主,证据质量低;SA成人38项/121例、儿童28项/142例,SE成人18项/37例、儿童5项/10例,DS成人21项/355例、儿童10项/90例。
  • 启动挥发性麻醉药后1–2小时内可见临床和生理改善,SA成人有效率89–95%、儿童80–97%,SE成人54–100%、儿童60–100%,DS成人60–90%、儿童62–90%。
  • 最常见不良事件为心血管事件,即低血压和心律失常。
  • SA/SE常用麻醉机输送吸入性镇静药,DS常用微型挥发器;仅10%的研究报告需要非ICU人员,仅16%有ICU挥发性麻醉药输送方案。
  • 作者结论:挥发性麻醉药可能对SA、SE和DS患者提供有效治疗,但证据质量低,需要更高质量的前瞻性研究及使用方案化。

适用人群与场景

  • 接受机械通气的成人ICU和PICU患者,诊断为哮喘持续状态(SA)、癫痫持续状态(SE)或困难镇静(DS)。

处置流程与药物剂量

  • SA/SE常用麻醉机输送吸入性镇静药,DS常用微型挥发器;仅16%的研究有ICU挥发性麻醉药输送方案。

红旗征与不能漏的情况

  • 最常见不良事件为心血管事件,即低血压和心律失常。

研究设计与关键结果

  • 系统评价共筛查4281项研究,纳入SA成人38项/121例、儿童28项/142例,SE成人18项/37例、儿童5项/10例,DS成人21项/355例、儿童10项/90例;证据质量低,以病例报告和病例系列为主。
  • 启动挥发性麻醉药后1–2小时内可见临床和生理改善,SA成人有效率89–95%、儿童80–97%,SE成人54–100%、儿童60–100%,DS成人60–90%、儿童62–90%。
  • 仅10%的研究报告需要非ICU人员,仅16%有ICU挥发性麻醉药输送方案。

证据类型、等级与局限

  • 证据类型:系统评价;质量评估使用Joanna Briggs Institute病例研究/系列评价工具、Newcastle标准(队列/病例对照研究)和临床试验偏倚风险框架;证据质量低,主要由病例报告和病例系列组成。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为挥发性麻醉药可能对SA、SE和DS患者提供有效治疗,但证据质量低;需要更高质量的前瞻性研究评估疗效和安全性,并需要开展吸入性麻醉药教育及使用方案化。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Inhaled volatile anesthetics support management of status asthmaticus (SA), status epilepticus (SE), and difficult sedation (DS). This study aimed to evaluate the effectiveness, safety, and feasibility of using inhaled anesthetics for SA, SE, and DS in adult ICU and PICU patients.

DATA SOURCES: MEDLINE, Cochrane Central Register of Controlled Trials, and Embase.

STUDY SELECTION: Primary literature search that reported the use of inhaled anesthetics in ventilated patients with SA, SE, and DS from 1970 to 2021.

DATA EXTRACTION: Study data points were extracted by two authors independently. Quality assessment was performed using the Joanna Briggs Institute appraisal tool for case studies/series, Newcastle criteria for cohort/case-control studies, and risk-of-bias framework for clinical trials.

DATA SYNTHESIS: Primary outcome was volatile efficacy in improving predefined clinical or physiologic endpoints. Secondary outcomes were adverse events and delivery logistics. From 4281 screened studies, the number of included studies/patients across diagnoses and patient groups were: SA (adult: 38/121, pediatric: 28/142), SE (adult: 18/37, pediatric: 5/10), and DS (adult: 21/355, pediatric: 10/90). Quality of evidence was low, consisting mainly of case reports and series. Clinical and physiologic improvement was seen within 1-2 hours of initiating volatiles, with variable efficacy across diagnoses and patient groups: SA (adult: 89-95%, pediatric: 80-97%), SE (adults: 54-100%, pediatric: 60-100%), and DS (adults: 60-90%, pediatric: 62-90%). Most common adverse events were cardiovascular, that is, hypotension and arrhythmias. Inhaled sedatives were commonly delivered using anesthesia machines for SA/SE and miniature vaporizers for DS. Few (10%) of studies reported required non-ICU personnel, and only 16% had ICU volatile delivery protocol.

CONCLUSIONS: Volatile anesthetics may provide effective treatment in patients with SA, SE, and DS scenarios but the quality of evidence is low. Higher-quality powered prospective studies of the efficacy and safety of using volatile anesthetics to manage SA, SE, and DS patients are required. Education regarding inhaled anesthetics and the protocolization of their use is needed.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Gorsky K, Cuninghame S, Jayaraj K, et al. Inhaled Volatiles for Status Asthmaticus, Epilepsy, and Difficult Sedation in Adult ICU and PICU: A Systematic Review. Crit Care Explor. 2024. PMID: 38384587. doi:10.1097/CCE.0000000000001050

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。